Hims & Hers Stock Declines Amid Revenue Misses and Market Concerns
TL;DR
Hims & Hers, a telehealth company known for weight-loss drugs, experienced a volatile quarter with a significant stock decline due to sales disappointments and market uncertainties, especially in its weight-loss and sexual health segments, raising questions about its long-term growth prospects.
Topics:business#business#hims-and-hers#market-uncertainty#stock-decline#telehealth#weight-loss-drugs
- Hims & Hers Stock Slides on Earnings. Weight-Loss Drugs Are Just One Problem. Barron's
- Hims & Hers stock slides 5% after second quarter revenue misses forecasts Yahoo Finance
- Hims & Hers stock falls 10% on revenue miss CNBC
- Investing in the Future of Healthcare Hims & Hers Newsroom
- IBD 50's Hims Dives. Why It Will Remain A 'Market Darling.' Investor's Business Daily
Want the full story? Read the original reporting
Read on Barron's